AngioDynamics to Present at Two Investor Conferences in May

AngioDynamics, Inc. (NASDAQ: ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease, surgery and oncology, today announced that it will present at the following two investor conferences in May:

Conference: Deutsche Bank 43rd Annual Healthcare ConferenceLocation: Boston, MADate: Tuesday, May 8, 2018Presentation: 3:30 p.m. ETSpeakers: Jim Clemmer, President and Chief Executive Officer, and Michael C. Greiner, Executive Vice President and Chief Financial Officer

Conference: UBS Global Healthcare ConferenceLocation: New York, NYDate: Monday, May 21, 2018Presentation: 9:00 a.m. ETSpeaker: Jim Clemmer, President and Chief Executive Officer

A live webcast of each presentation will be accessible through the “Investors” section of the Company’s website at www.angiodynamics.com and will be available for replay following each event.

About AngioDynamics, Inc.

AngioDynamics, Inc. is a leading provider of innovative, minimally invasive medical devices used by professional healthcare providers for vascular access, surgery, peripheral vascular disease and oncology. AngioDynamics’ diverse product lines include market-leading ablation systems, fluid management systems, vascular access products, angiographic products and accessories drainage products, thrombolytic products and venous products. For more information, visit www.angiodynamics.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20180410006393/en/

Investors:AngioDynamics, Inc.Michael C. Greiner, 518-795-1821Executive Vice President & CFO

AngioDynamics (NASDAQ:ANGO)
Historical Stock Chart
From Apr 2024 to May 2024